November 20, 2026 · AI Tech
IBM Technology released a video explaining how artificial intelligence can predict whether drug candidates will be toxic or poorly absorbed before expensive clinical trials begin. The core challenge in cancer treatment is not just killing cancer cells but ensuring patients survive the side effects of the drugs meant to help them.
AI models trained on chemical and biological data can forecast drug toxicity and solubility—how well a drug dissolves and reaches target tissues—early in the discovery process. This prediction step could filter out problematic compounds before they reach human testing, saving time and money in pharmaceutical development.
This is an AI-written summary. The original reporting belongs to @IBMTechnology. How we write these · Spot a mistake?
Get the AI brief every morning.
The five AI stories that matter each morning: startups, money, jobs, tech and what's coming next. Free, and one click to unsubscribe. See our Privacy Policy.